CVS
27
2
UA
48
6
TGNA
48
5
CHD
34
7
CAG
34
3
PWR
63
3
CPB
24
2
GOOGL
62
6
CME
59
3
AMT
30
2
LUV
45
3
FOX
71
3
RF
44
10
EQT
47
13
JBHT
46
4
PH
60
5
GWW
50
9
DVA
62
5
A
43
2
OXY
42
17
CVS
27
2
UA
48
6
TGNA
48
5
CHD
34
7
CAG
34
3
PWR
63
3
CPB
24
2
GOOGL
62
6
CME
59
3
AMT
30
2
LUV
45
3
FOX
71
3
RF
44
10
EQT
47
13
JBHT
46
4
PH
60
5
GWW
50
9
DVA
62
5
A
43
2
OXY
42
17
Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
14

VIR
Vir Biotechnology

Last Price:
$7.36
Seasonality Move:
61.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.

Vir Biotechnology Price Quote

$7.36
+0.02 (+-0.14%)
(Updated: December 21, 2024 at 5:53 AM ET)

Vir Biotechnology Key Stats

Sell
14
Vir Biotechnology (VIR) is a Sell
Day range:
$7.23 - $7.56
52-week range:
$6.56 - $13.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.06
P/B ratio:
0.81%
Volume:
3.4M
Avg. volume:
1.5M
1-year change:
-23.62%
Market cap:
$1B
Revenue:
$39.5M
EPS:
$-3.92

How Much Does Vir Biotechnology Make?

Data Unavailable

Is Vir Biotechnology Growing As A Company?

Data Unavailable

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went up by 8.9% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -23.62% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

Data Unavailable

Is Vir Biotechnology Cash Flow Positive?

Data Unavailable

Vir Biotechnology Return On Invested Capital

Data Unavailable

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

  • Who Are Vir Biotechnology's Competitors?
    Below is a list of companies who compete with Vir Biotechnology or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • GlycoMimetics Inc (GLYC)
    • Janux Therapeutics Inc (JANX)

Vir Biotechnology Dividend Yield

Data Unavailable

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -43.97%
Revenue: 9.62% -56.81%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 31.25
Upside from Last Price: 325.75%

Major Shareholders

Data Unavailable